Inside informationEnglish
OSE Immunotherapeutics Appoints Thomas Gidoin as Chief Financial Officer
The file is served by the AMF. We do not host a copy.
Document type
- Issuer
- Ose Immunotherapeutics
- Filed
- 20/08/2025, 18:00
- Document type
- Inside information
- AMF sub-type
- Informations privilégiées
- Language
- English
- AMF reference
- 113777_20250820